Gender and contemporary risk of adverse events in atrial fibrillation

Removal of gender from clinical risk scoring could simplify the approach to which patients with AF should be offered oral anticoagulation.

Authors

Institutions

Publication Details

Journal
European Heart Journal
Published
2024-09-01
DOI
https://doi.org/10.1093/eurheartj/ehae539
Citations
50
Primary Topic
Atrial Fibrillation Management and Outcomes
Type
article
Field-Weighted Citation Impact
20.10

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Gender and contemporary risk of adverse events in atrial fibrillation

Dipak Kotecha, Isabelle C. Van Gelder, Stylianos E. Tzeis, Luigina Guasti et al.
50 citations
European Heart Journal
Atrial Fibrillation Management and Outcomes
20.10
article

Gender and contemporary risk of adverse events in atrial fibrillation

Dipak Kotecha, Isabelle C. Van Gelder, Stylianos E. Tzeis, Luigina Guasti, Karina V Bunting, Krishnarajah Nirantharakumar, Alastair Mobley, David Shukla, Bart Maesen, Otilia Țica, Michiel Rienstra, Rubén Casado-Arroyo, Maddalena Lettino, VASSIL BORISLAVOV TRAYKOV, R Thomas Lumbers, Xiaoxia Wang, Anuradhaa Subramanian, Harry J.G.M. Crijns, Emma Svennberg, Inge Mølgaard, Jeremy Dwight
article en
50 citations

Abstract

Removal of gender from clinical risk scoring could simplify the approach to which patients with AF should be offered oral anticoagulation.

European Heart JournalVol. 45(36)
University of Insubria (IT), University Hospitals Birmingham NHS Foundation Trust (GB), Université Libre de Bruxelles (BE), University Medical Center Groningen (NL), Karolinska University Hospital (SE), University of Oradea (RO), University of Groningen (NL), Queen Elizabeth Hospital Birmingham (GB), Tokuda Hospital (BG), Erasmus Hospital (BE), University Medical Center (US), Karolinska Institutet (SE), European Society of Cardiology (FR), Maastricht University (NL), Acibadem City Clinic (BG), Queen Elizabeth Hospital (GB), Azienda Ospedaliera San Gerardo (IT), Mitera Hospital (GR), UCL Biomedical Research Centre (GB), Istituti di Ricovero e Cura a Carattere Scientifico (IT), NIHR Birmingham Biomedical Research Centre (GB), University College London (GB), University of Birmingham (GB)
Bristol-Myers Squibb, Pioneer Fund, Pfizer, AtriCure, Boston Scientific Corporation, European Federation of Pharmaceutical Industries and Associations, UK Research and Innovation, National Institute for Health and Care Research, British Heart Foundation, University of Oxford, European Commission, European Society of Cardiology, ZonMw, Stockholms Läns Landsting, Vetenskapsrådet, National Institutes of Health, Medical Research Council, Center for Innovative Medicine, Birmingham Biomedical Research Centre, Daiichi Sankyo Europe
Openalex Percentile: Top 0%
Atrial Fibrillation Management and Outcomes
20.10
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.